Supriya Gupta

USPTO Granted Patents = 15 (Patent Applications = 6)

CIPO Patents = 4 (Patent Applications = 6)

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 4.8

ph-index = 6

Forward Citations = 98(Granted Patents)

Location History:

Sunnyvale, CA (US) (2009 - 2018)
Waverly, IA (US) (2020 - 2023)

Company Filing History:

9 out of 9

Ekr Therapeutics, Inc.

Facet Biotech Corporation

patents

4. 1 out of 51

Abbvie Biotherapeutics Inc.

patents

Years Active: 2009-2023

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11547758 - Pre-mixed, ready-to-use pharmaceutical compositions (2023-01-10),

2. 10758616 - Pre-mixed, ready-to-use pharmaceutical compositions (2020-09-01),

3. 9944720 - Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof (2018-04-17),

4. 9549994 - Compositions of nicardipine and sulfoalkylated β-cyclodextrin (2017-01-24),

5. 9370586 - Methods of preparing pre-mixed, ready-to-use pharmaceutical compositions (2016-06-21),

6. 9364564 - Pre-mixed, ready-to-use pharmaceutical compositions (2016-06-14),

7. 9163093 - Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof (2015-10-20),

8. 9045551 - Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof (2015-06-02),

9. 8465739 - Stable aqueous pharmaceutical formulations of daclizumab antibodies (2013-06-18),

10. 8455524 - Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions (2013-06-04),

11. 8298530 - Stable lyophilized pharmaceutical formulation of IgG antibodies (2012-10-30),

12. 7659291 - Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions (2010-02-09),

13. 7659290 - Methods of preparing pre-mixed, ready-to-use pharmaceutical compositions (2010-02-09),

14. 7612102 - Pre-mixed, ready-to-use pharmaceutical compositions (2009-11-03),

15. 7592004 - Stable lyophilized pharmaceutical formulation of IgG antibodies (2009-09-22),

Title: Celebrating the Innovations of Supriya Gupta

Introduction

Supriya Gupta, an accomplished inventor based in Sunnyvale, California, has made significant contributions to the pharmaceutical industry. With a remarkable portfolio of 15 patents, her work primarily focuses on developing innovative solutions for cardiovascular and cerebrovascular conditions.

Latest Patents

Among her latest advancements, Gupta has patented ready-to-use premixed pharmaceutical compositions featuring nicardipine and its pharmaceutically acceptable salts. These compositions aim to provide efficient treatment methodologies for patients dealing with cardiovascular and cerebrovascular issues, showcasing her dedication to improving healthcare outcomes.

Career Highlights

Throughout her career, Supriya Gupta has held pivotal positions in notable companies such as EKR Therapeutics, Inc. and AbbVie Inc. Her expertise and dedication have been instrumental in driving forward innovative projects that have a meaningful impact on patient care.

Collaborations

Gupta has worked alongside talented colleagues in the industry, including Camellia Zamiri and Michelle Renee Duncan. These collaborations have not only enriched her professional journey but have also led to the successful development of groundbreaking pharmaceutical products.

Conclusion

Supriya Gupta's impressive array of patents and her commitment to advancing pharmaceutical innovations underline her vital role in the medical field. Her contributions will undoubtedly continue to inspire future generations of inventors and researchers striving to enhance healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.